Journal article

Strumpellin is a novel valosin-containing protein binding partner linking hereditary spastic paraplegia to protein aggregation diseases

CS Clemen, K Tangavelou, KH Strucksberg, S Just, L Gaertner, H Regus-Leidig, M Stumpf, J Reimann, R Coras, RO Morgan, MP Fernandez, A Hofmann, S Müller, B Schoser, FG Hanisch, W Rottbauer, I Blümcke, S Von Hörsten, L Eichinger, R Schröder

Brain | OXFORD UNIV PRESS | Published : 2010

Abstract

Mutations of the human valosin-containing protein gene cause autosomal-dominant inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. We identified strumpellin as a novel valosin-containing protein binding partner. Strumpellin mutations have been shown to cause hereditary spastic paraplegia. We demonstrate that strumpellin is a ubiquitously expressed protein present in cytosolic and endoplasmic reticulum cell fractions. Overexpression or ablation of wild-type strumpellin caused significantly reduced wound closure velocities in wound healing assays, whereas overexpression of the disease-causing strumpellin N471D mutant showed no functional effect. Strumpel..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Deutsche Forschungsgemeinschaft


Funding Acknowledgements

The German Research Foundation (DFG: SCHR 562/7-1, CL 381/1-1; DFG/FOR1228: SCHR 562/9-1, CL 381/3-1, EI 399/5-1); Fritz-Thyssen-Foundation (grant 10.07.1.165 to R. S. and C. S. C.); German ministry of education and research, (BMBF) (via the German network on muscular dystrophies (MD-NET2) to R. S. and C. S. C.); Spanish Ministry of Science and Innovation (MICINN) (grant BFU2007-67876 to R.O.M. and M.-P. F.).